Literature DB >> 9039289

Constitutive endothelial and inducible nitric oxide synthase in inflammatory dermatoses.

A Rowe1, A M Farrell, C B Bunker.   

Abstract

We have used immunohistochemistry to localize the expression of the constitutive endothelial and inducible forms of the enzyme nitric oxide synthase (NOS) in skin from involved and uninvolved sites in patients with atopic dermatitis (AD) and allergic contact dermatitis (CD). Endothelial NOS (eNOS) immunoreactivity was localized to vascular endothelium in the dermis of both involved and uninvolved skin from all patients. Inducible NOS (iNOS) immunoreactivity was found to be closely associated with the upper dermal microvasculature in all the involved AD biopsies, but only in two of 10 uninvolved AD biopsies. CD biopsies were taken from 10 positive skin patch test sites and iNOS immunoreactivity was detected in all of these. iNOS immunoreactivity was detected in only one of the negative patch test biopsies. Both the extent and intensity of iNOS immunoreactivity was lower in CD than in AD skin lesions. The presence of eNOS in the skin is necessary for constitutive NO-mediated dilatation of the dermal vasculature. Induction of iNOS in the dermal endothelium and in perivascular inflammatory cells may be significant with respect to the roles of NO in both the vasodilatory component of the inflammatory response and in the modulation of immune responses in the skin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9039289

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  18 in total

Review 1.  Inducible nitric oxide synthase in human diseases.

Authors:  K D Kröncke; K Fehsel; V Kolb-Bachofen
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

2.  Sequential changes in trace metal, metallothionein and calmodulin concentrations in healing skin wounds.

Authors:  A B Lansdown; B Sampson; A Rowe
Journal:  J Anat       Date:  1999-10       Impact factor: 2.610

3.  Role of nitric oxide in the regulation of microvascular perfusion in human skin in vivo.

Authors:  G F Clough
Journal:  J Physiol       Date:  1999-04-15       Impact factor: 5.182

4.  Bryonolic acid transcriptional control of anti-inflammatory and antioxidant genes in macrophages in vitro and in vivo.

Authors:  Tonibelle N Gatbonton-Schwager; John J Letterio; Gregory P Tochtrop
Journal:  J Nat Prod       Date:  2012-02-16       Impact factor: 4.050

Review 5.  Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin.

Authors:  Sanjoy Roychowdhury; Craig K Svensson
Journal:  AAPS J       Date:  2005-12-09       Impact factor: 4.009

6.  Identification of copper/zinc superoxide dismutase as a nitric oxide-regulated gene in human (HaCaT) keratinocytes: implications for keratinocyte proliferation.

Authors:  S Frank; H Kämpfer; M Podda; R Kaufmann; J Pfeilschifter
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

7.  Free radical production requires both inducible nitric oxide synthase and xanthine oxidase in LPS-treated skin.

Authors:  Kozo Nakai; Maria B Kadiiska; Jin-Jie Jiang; Krisztian Stadler; Ronald P Mason
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-14       Impact factor: 11.205

8.  Nitric oxide donors suppress chemokine production by keratinocytes in vitro and in vivo.

Authors:  Maria Laura Giustizieri; Cristina Albanesi; Claudia Scarponi; Ornella De Pità; Giampiero Girolomoni
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

9.  Nitric oxide levels in patients with psoriasis treated with methotrexate.

Authors:  Nilgun Solak Tekin; Nilsel Ilter; Banu Sancak; Muge Guler Ozden; Mehmet Ali Gurer
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

10.  Dexamethasone prevents granulocyte-macrophage colony-stimulating factor-induced nuclear factor-kappaB activation, inducible nitric oxide synthase expression and nitric oxide production in a skin dendritic cell line.

Authors:  Ana Luísa Vital; Margarida Gonçalo; M Teresa Cruz; Américo Figueiredo; Carlos B Duarte; M Celeste Lopes
Journal:  Mediators Inflamm       Date:  2003-04       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.